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Abstract
Little is known about the interrelationships between maternal and infant erythrocyte-DHA, milk-DHA and maternal adipose tissue
(AT)-DHA contents. We studied these relationships in four tribes in Tanzania (Maasai, Pare, Sengerema and Ukerewe) differing in their
lifetime intakes of fish. Cross-sectional samples were collected at delivery and after 3 d and 3 months of exclusive breast-feeding. We
found that intra-uterine biomagnification is a sign of low maternal DHA status, that genuine biomagnification occurs during lactation,
that lactating mothers with low DHA status cannot augment their infants’ DHA status, and that lactating mothers lose DHA independent
of their DHA status. A maternal erythrocyte-DHA content of 8 wt% was found to correspond with a mature milk-DHA content of
1·0 wt% and with subcutaneous and abdominal (omentum) AT-DHA contents of about 0·39 and 0·52 wt%, respectively. Consequently,
1 wt% DHA might be a target for Western human milk and infant formula that has milk arachidonic acid, EPA and linoleic acid contents
of 0·55, 0·22 and 9·32 wt%, respectively. With increasing DHA status, the erythrocyte-DHA content reaches a plateau of about 9 wt%, and it
plateaus more readily than milk-DHA and AT-DHA contents. Compared with the average Tanzanian-Ukerewe woman, the average
US woman has four times lower AT-DHA content (0·4 v. 0·1 wt%) and five times lower mature milk-DHA output (301 v. 60 mg/d),
which contrasts with her estimated 1·8–2·6 times lower mobilisable AT-DHA content (19 v. 35–50 g).
Key words: DHA: Breast milk: Tanzania: Adipose tissue: Erythrocytes
The long-chain PUFA (LCP) DHA, EPA and arachidonic acid
(AA) are structural components of membrane phospholipids
and precursors of the biologically highly active eicosanoids,
neuroprotectins, maresins and resolvins(1,2). LCP derive from
endogenous synthesis from the essential fatty acids linoleic
acid (AA) and a-linolenic acid (EPA and DHA) or from diets
containing AA, which is abundant in meat, eggs, poultry and
(lean) fish, and EPA and DHA, which are notably abundant
in (fatty) fish. High DHA contents are found in the retina, cer-
ebral cortex and sperm, while AA is more evenly distributed
among the various organs(3). Low LCP n-3 status may notably
be involved in abnormal neurodevelopment, CVD and psy-
chiatric disease, and many trials have been conducted with
either purified fish oil or purified EPA for the improvement
of neurodevelopment and the primary and secondary preven-
tion of CVD and (neuro)psychiatric disease, including
depression(4) and Alzheimer’s disease(5).
Little is known about the interrelationships between
maternal erythrocyte-DHA, infant erythrocyte-DHA, maternal
adipose tissue (AT)-DHA and milk-DHA contents. For a
greater part, the fetus is dependent on the transplacental
passage of LCP, notably DHA, because of its limited synthesis
capacity in relation to its high needs for growth and develop-
ment. This transplacental passage may cause maternal LCP n-3
depletion, which is notably related to postpartum depression,
while insufficient fetal LCP n-3 accretion is, for example,
related to attention deficit disorder(6) and diseases at later
age(7). At delivery, infants may have higher LCP amounts
in plasma lipid fractions and erythrocytes than their
mothers, which has been coined biomagnification(8,9). LCP
in erythrocytes are generally accepted as reliable markers
of the intermediate-term LCP status(10). The optimal
erythrocyte 2 (EPA þ DHA) content, coined the n-3 index,
for the prevention of CVD(11) and major depressive disorders
and bipolar depression(4,12) has been estimated to be
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about 8 wt%. We have recently calculated that a maternal
erythrocyte-DHA content of about 8 wt% at delivery is likely
to prevent (serious) DHA depletion in lactating women(13).
The AT-DHA and milk-DHA contents that correspond with
this erythrocyte-DHA content are presently unknown.
The essential fatty acids and LCP present in milk derive
either from the diet or from the synthesis of LCP, but mostly
from the maternal AT compartment. Dependent on age, sex
and race/ethnicity, the body fat percentage of US adults is
typically 28·1 % for men and 40 % for women(14), of which
2–5 % is essential fat in men and 10–13 % in women(15).
This renders the remaining potentially mobilisable storage
fat, among the principle sites where LCP are present. Despite
high brain-DHA contents, most DHA is present in the AT. We
have recently estimated that the distribution of whole-body
DHA in a 40-week, 3·5 kg term infant is 50 % in the AT,
23 % in the brain, 21 % in the skeletal muscle and 6·5 % in
the liver, while the percentages of DHA in total fatty acids
in these organs are (in g/100 g fatty acids; wt%) 7·76 (brain),
4·08 (liver), 3·51 (skeletal muscle) and 0·3 (AT) wt%(16).
In the present study, we explored the interrelationships
between the following: (1) the erythrocyte-DHA contents of
mothers and infants at delivery and 3 months postpartum;
(2) the milk-DHA contents at 3 d and 3 months postpartum;
(3) the maternal subcutaneous and abdominal (omentum)
AT-DHA contents at delivery. Samples were collected from
four tribes in Tanzania differing in their lifetime intakes of
fish: Maasai (no fish); Pare (two to three times fish/week);
Sengerema (four to five times fish/week); Ukerewe (.7 times
fish/week). Data on AT and milk-DHA contents are new,
which part of the data on erythrocytes have been published
previously, although not in relation to the current milk
and AT data(13,17). We were particularly interested in the
following: (1) the magnitudes of the intra-uterine and post-
partum biomagnifications of DHA as a function of the DHA
status; (2) the mature milk-DHA content that is achieved at a
maternal erythrocyte-DHA content of 8 wt%; (3) the AT-DHA
content at which the erythrocyte-DHA content reaches a
plateau; (4) a comparison of the whole-body AT-DHA
contents and milk-DHA outputs of the average Tanzanian-
Ukerewe woman and the average US woman.
Materials and methods
Subjects, diets and cultural habits
As study groups, we selected women and their infants from
four Tanzanian ethnic tribes with different intakes of local
freshwater fish, i.e. the Maasai (no or low fish intake, zero
times/week), a tribe from the Pare Mountains (intermediate
fish intake, two to three times/week), a tribe from Sengerema
(high fish intake, four to five times/week), and a tribe from
Ukerewe (very high fish intake, .7 times/week). The selected
Maasai were Nilotic pastoralists living in ‘bomas’ (villages) in
the Maasai Steppe near Ruvu. Their diet mainly consists of
curdled milk and meat. They have recently included ugali
(maize porridge) in their diet. The consumption of fish is
uncommon, since it is considered inedible. The second
study group consisted of women and infants from two
Bantu tribes, the Pare and the Sambaa, from the Pare Moun-
tains near Same. Their diet mainly consists of vegetables,
beans and fruits with ample amounts of ugali, rice and chapati
(maize flour pancakes) and some meat and fish. The third
study group was the Bantu tribe comprising women and
infants from Sengerema (southern shore of Lake Victoria),
and the fourth study group was the Bantu population compris-
ing women and infants from Ukerewe, an island in Lake
Victoria. Apart from the abundant consumption of fish, the
latter two tribes also consume ugali, muhogo (cassava root),
beans and plantain (baked banana). Importantly, one of the
locally most abundant fish species (a sardine, Rastrineobola
argentea) is eaten as butter to bread, but it is not considered
as a fish by this people, but as a vegetable.
The ethnicity/tribe of each of the study groups was con-
sidered to be homogeneous. Most of the women had a low
socio-economic background, meaning low education levels.
With regard to feeding practice, they were well nourished,
with a low intake of highly refined carbohydrates and regular
intakes of fruits, vegetables and unprocessed meat and
fish. They earned their incomes from pastoralism (Maasai),
agriculture (Pare) or fisheries (Sengerema/Ukerewe). The
study populations had neither possibilities of nor interest in
changing their cultural habits, including their diets. Interviews
with the local hospital staff and the participants confirmed
that neither pregnancy nor lactation was associated with
any change in dietary habits or the prohibition of consump-
tion of certain foods (F Peters, RS Kuipers, FAJ Muskiet,
unpublished results). Therefore, the diets are likely to be
representative of the lifelong dietary habits of each of the
ethnic groups. The use of tobacco and alcohol is almost
non-existent in these populations, especially among women.
Women and infants were included in the study if they were
apparently healthy and well nourished, and women were
included if they had delivered an apparently healthy term
child (37–42 weeks, by estimate) the same day (delivery
group) or 10–20 weeks before their visit to the local hospital
or dispensary (3 months postpartum group). Anthropometric
data and data on fish intake collected using a questionnaire
were obtained from the medical records or through interviews
in Kiswahili. Apart from the measurement of fundal heights,
reliable data on gestational age were not available always,
since some women had no recollection of their last menstrual
period. Devices for echo imaging were either not available or
not operational. Consequently, gestational ages were esti-
mated from the sum of the available data. All the women
gave their informed consent. The study was approved by
the National Institute for Medical Research in Dar-es-Salaam
(NIMR/HQIR.8a/Vol. IX/145, dated 16 June 2003 and NIMR/
HQ/R.8a/Vol. IX/800, dated 8 April 2009) and complied with
the Declaration of Helsinki of 1975 as revised in 2000.
Sample collection and analyses
We collected about 4 ml of EDTA-anticoagulated venous blood
from the mothers and about 4 ml of EDTA-anticoagulated cord
blood at delivery (BD Vacutainer). At 3 months postpartum,
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about 4 ml of EDTA-anticoagulated venous blood were col-
lected from the mothers. About 250ml of EDTA-anticoagulated
blood (250ml paediatric MiniCollect K3EDTA tubes; Greiner
Bio-one) were collected by heel prick from 3-month-old
infants. The samples were stored at 4 8C in the dark and
processed within 2 h of collection. Erythrocytes were isolated
by centrifugation and washed three times with 0·9 % NaCl.
After washing, 200ml of the 50 % haematocrit erythrocyte
suspension (mothers) or the entire erythrocyte suspension
(infants) was transferred into a Teflon-sealable tube (Sovirel).
We collected 5 ml of breast milk shortly after delivery (usually
3 d postpartum) and at 3 months postpartum. Following gentle
mixing, 100ml of milk were transferred into a Teflon-sealable
tube (Sovirel). We were able to collect about 1 cm3 of sub-
cutaneous (abdominal wall) and abdominal (omentum) AT
from some of the women during emergency Caesarean
section. Caesarean section was carried out for various reasons,
including fetal distress and obstructed labour. The reasons for
carrying out Caesarean section had not influenced the
general health of the mothers and their infants and were con-
sidered to not have affected the DHA status or the distribution
of DHA across the fetomaternal unit. The AT samples were
transferred into Teflon-sealable tube (Sovirel).
All the Sovirel tubes contained 2 ml of methanol–6 mol/l
HCl (5:1, v/v), 1 mg of butylated hydroxytoluene (antioxidant)
and 50mg of 17:0. They were stored and transported at ambient
temperature to the University Medical Center Groningen
(The Netherlands) for fatty acid analysis. All the samples
were processed and analysed within 9 months of collection.
The partly dissolved AT samples were pottered (Potter appar-
atus), and chloroform–methanol (2:1) was added until a sus-
pension of about 10 ml was obtained. Into a Sovirel tube,
100ml of this solution were transferred, followed by the
addition of 500ml of chloroform and 2 ml of methanol–HCl
(5:1, v/v). All the samples were transmethylated by heating
at 908C for 4 h. Subsequent analysis of fatty acid methyl
esters was carried out by capillary GC/flame ionisation detec-
tion essentially according to previously described pro-
cedures(18). The long-chain fatty acids were quantified on
the basis of the added 17:0. In milk, medium-chain fatty
acids (6:0 up to 14:0) were quantified using 5:0–15:0 as the
internal quantification standards(19). Fatty acid compositions
are expressed in g/100 g fatty acids (wt%).
Estimations of the whole-body adipose tissue-DHA
contents and the milk-DHA outputs
We estimated the total amount of DHA in the mobilisable AT
compartment and the milk-DHA outputs of an average
Tanzanian-Ukerewe woman with an erythrocyte-DHA content
of 8 wt% and compared the outcomes with those of an
average US woman, typically having an erythrocyte-DHA
content of 3·71 wt%. For the Tanzanian-Ukerewe woman, we
used the AT-DHA and mature milk-DHA contents that
corresponded with an erythrocyte-DHA content of 8 wt%.
Her body fat percentage was calculated using the formula of
Deurenberg et al.(20):
Body fat percentage ¼1·20 £ BMIþ 0·23 £ age2 10·8
£ sex2 5·4;
where female sex ¼ 0. Her body fat percentage was also
estimated using the formula of Gallagher et al.(21): body fat
percentage ¼ 76–1097·8/BMI þ 0·053 £ age (for females).
The outcomes of the Deurenberg and Gallagher formulas
were averaged. We also used the body fat percentage as genu-
inely measured in 196 well-nourished African women (BMI 22·5
(SD 4·6) kg/m2) living in the pre-urban neighbourhood of Dakar
(Senegal, West Africa), who had a mean age of 29·5 years, a
mean BMI of 22·5 kg/m2 and a mean body fat percentage of
34·2 %, as determined by air-displacement plethysmogra-
phy(22). The essential body fat percentage for women was esti-
mated to be 11·5 % of body weight (mean of 10–13 %(15)). These
data together with a mean fat percentage in the wet AT of
adults(23) allowed us to estimate the percentage and amount
of mobilisable storage fat, the amount and percentage of mobi-
lisable wet AT, and the amount of DHA in mobilisable wet AT.
For the calculation of the colostrum-DHA and mature milk-
DHA outputs, we used the colostrum and mature milk volumes
at day 3 and at 3 months, respectively, as reported by Neville
et al.(24), while the colostrum and mature milk fat contents
were derived from the studies of Jensen(25,26).
For the average US woman, we used the data on mean body
weight, body length and BMI from the NHANES 2003–6 for the
age group 20–39 years(27). The body fat percentage was derived
from the NHANES 1999–2004(14), while the erythrocyte-DHA
content was derived from the ‘Nurses’ Health Study’(28). The
women in the latter study were, on average, 60 years old, but
this was not considered a confounder because of the major influ-
ence of diet on the erythrocyte-DHA content, although fish intake
may increase with age. The AT-DHA content was derived from
the study of Leaf et al.(29). The mature milk-DHA content for the
USA was derived from the study of Brenna et al.(30), while the
colostrum-DHA content was estimated from other countries
that exhibited similar mature milk-DHA contents as the USA(31).
Statistical analyses
Statistical analyses were carried out with SPSS version 18.0
(SPSS, Inc.). Between-group differences were studied with
the Kruskal–Wallis test, followed by analyses with the
Mann–Whitney U test (non-parametric) at P , 0·05. Analyses
of mother–infant pairs were carried out with the Wilcoxon
two-related sample tests. Corrections were made for type 1
errors (Bonferroni correction). Equations were derived from
curve estimation. We used the coefficient of determination
(R 2) to estimate the extent to which a given variable was
explained by another; P , 0·05 was considered significant.
Results
Study groups
We included ninety mother–infant pairs at delivery (six
Maasai, twenty-three Pare, thirty-four Sengerema and
twenty-seven Ukerewe) and 125 other mother–infant pairs
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after about 3 months of exclusive breast-feeding (eight
Maasai, thirty-six Pare, sixty-one Sengerema and twenty
Ukerewe). Their characteristics are summarised in Table 1.
There were no between-tribe differences in anthropometrics
for the mothers and infants at delivery, except for a higher
BMI in the Pare women than in the other women at delivery.
The Ukerewe mothers studied at 3 months postpartum were
older than the corresponding Pare and Sengerema mothers
and they were also taller than the Pare mothers. The BMI of
the Maasai mothers was lower than that of the Sengerema
mothers. The Ukerewe mothers who were included at
3 months postpartum had delivered more children than the
Pare and Sengerema mothers. The order of fish consumption
in the study groups was Ukerewe . Sengerema . Pare .
Maasai, both at delivery and at 3 months postpartum.
Erythrocyte-DHA, milk-DHA and adipose tissue-DHA
contents in the mother–infant pairs
Table 2 summarises the medians (ranges) of the erythrocyte-
DHA, milk-DHA and AT-DHA contents of the four tribes at
delivery/3 d postpartum and at 3 months postpartum.
Complete fatty acid compositions are given in Tables S1–S3
(available online). We have previously shown that the
erythrocyte-DHA content increases with increasing fish
intakes(13). At delivery, the Sengerema (P , 0·05) and Ukerewe
(P , 0·001) mothers had higher erythrocyte-DHA contents than
their infants, whereas the erythrocyte-DHA contents of the
Maasai and Pare mothers were insignificantly lower than those
of their infants (intra-uterine biomagnification). At 3 months
postpartum, all the infants had significantly higher erythrocyte-
DHA contents than their mothers, indicating postpartum
biomagnification. In the infant groups, the Maasai infants had
lower erythrocyte-DHA contents at 3 months postpartum than
their counterparts at delivery (P , 0·05). The Pare and Ukerewe
infants at delivery did not exhibit significant differences in
erythrocyte-DHA contents compared with their counterparts at
3 months postpartum, whereas the Sengerema infants had
higher erythrocyte-DHA contents at 3 months postpartum
than the Sengerema infants at delivery (P , 0·05). In all
the populations, the maternal erythrocyte-DHA content at
3 months postpartum was lower than that at delivery, indicating
maternal postpartum DHA depletion, irrespective of the DHA
status at delivery.
The mature milk-DHA content of the Sengerema mothers at
3 months postpartum (0·68 wt%) was lower than their colos-
trum-DHA content (0·81 wt%) (P ¼ 0·047). The mature milk-
DHA content of the Ukerewe mothers (0·96 wt%) at 3 months
postpartum was higher than that of the Sengerema mothers
(P ¼ 0·001). Subcutaneous and abdominal AT-DHA contents
appeared to be dependent on fish intake and increased in the
study groups in the order Sengerema . Pare . Maasai,
although only the differences between the Pare and the Senger-
ema mothers reached significance (P,0·001), possibly because
of the small sample size of the Maasai group.
Table 1. Characteristics of the mother–infant pairs of four Tanzanian tribes studied at delivery or 3 months postpartum
(Number of participants, mean values and standard deviations)
Maasai Pare Sengerema Ukerewe
n Mean SD n Mean SD n Mean SD n Mean SD
Delivery/3 d postpartum
Maternal age (years) 6 23 5 23 24 7 34 24 7 27 26 7
Postpartum weight (kg) 6 53·0 5·7 18 57·7 6·8 31 54·4 10·2 27 54·6 6·0
Height (m) 6 1·59 0·06 21 1·54 0·04 31 1·56 0·06 27 1·57 0·03
BMI (kg/m2) 6 21·0b 2·3 18 24·2a 2·0 31 22·4b 3·3 27 22·2b 2·0
Gravida (n) 6 3 1 23 2 2 34 3 3 27 4 3
Para (n) 6 2 1 23 1 1 34 2 3 27 2 3
Gestational age at birth
(weeks)
1 40·0 0 7 39·9 1·1 28 38·9 1·8 21 38·3 2·7
Fish intake (times/week) 6 0d 0 14 3c 2 30 5b 2 27 7a 0
Infant birth weight (g) 6 3067 467 21 3188 529 34 2947 751 27 2904 751
Male
n 6 22 36 26
% 33 50 58 46
3 months postpartum
Maternal age (years) 8 23a,b 4 36 24b 4 61 24b 6 20 28a 9
Postpartum weight (kg) 8 53·0 5 36 52·9 11·2 61 54·6 10·0 20 56·8 7·6
Height (m) 8 1·59a,b 0·06 36 1·55b 0·07 61 1·56a,b 0·06 20 1·57a 0·07
BMI (kg/m2) 8 20·9b 2·0 36 21·9a,b 4·1 61 22·1a 3·0 20 22·9a,b 2·2
Para (n) 9 3a,b 1 36 2b 1 61 3b 2 20 4a 3
Fish intake (times/week) 8 0d 0 36 3c 2 61 4b 2 20 7a 0
Infant age (weeks) 8 15 4 36 14b 3 61 13b 2 20 12·5 3·8
Male
n 8 36 61 20
% 75 44 55 35
a,b,c,d Mean values with unlike superscript letters were significantly different (P , 0·05).
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Interrelationships between erythrocyte-DHA, milk-DHA
and adipose tissue-DHA contents
Fig. 1 shows the positive relationship of maternal erythrocyte-
DHA content at delivery with colostrum-DHA content at 3 d
postpartum for women with high fish intakes (Sengerema,
n 30; R 2 0·510; P , 0·001; Fig. 1(a)), together with the
relationship of maternal erythrocyte-DHA content with
mature milk-DHA content at 3 months postpartum (Senger-
ema (n 47) and Ukerewe (n 20); R 2 0·360; P , 0·001;
Fig. 1(b)). A maternal erythrocyte-DHA content of 8 wt% was
found to correspond with 1 wt% DHA in both colostrum
(Fig. 1(a)) and mature milk (Fig. 1(b)). Fig. 2 shows the posi-
tive, non-linear relationships of the subcutaneous (R 2 0·436;
P , 0·001; Fig. 2(a)) and abdominal (R 2 0·432; P , 0·001;
Fig. 2(b)) AT-DHA contents with the maternal erythrocyte-
DHA contents at delivery. We estimated that a maternal
erythrocyte-DHA content of 8 wt% corresponds with
subcutaneous and abdominal AT-DHA contents of 0·39 and
0·52 wt%, respectively.
Fig. 3 shows the positive, non-linear relationships of the
subcutaneous (R 2 0·193; P ¼ 0·015; Fig. 3(a)) and abdominal
(R 2 0·255; P , 0·004; Fig. 3(b)) AT-DHA contents at delivery
with the colostrum-DHA contents at 3 d postpartum. A
milk-DHA content of 1 wt% was found to correspond with
subcutaneous and abdominal AT-DHA contents of 0·35 and
0·40 wt%, respectively. Fig. 4 shows the positive relationship
between the subcutaneous and abdominal AT-DHA contents
(R 2 0·690; P , 0·001). The abdominal AT-DHA contents
proved to be, on average, 29 (SD 50·8) % (250·0 to 133·3)
higher than the subcutaneous AT-DHA contents (P,0·001).
Estimated milk-DHA output and whole-body adipose
tissue-DHA content
The body fat percentage of the average Tanzanian-Ukerewe
woman amounted to 27·2 when calculated according to the
formula of Deurenberg et al.(20) and 27·9 % when calculated
according to the formula of Gallagher et al.(21), which aver-
aged to 27·5 % (Table 3). The body fat percentage of the 196
women living in the pre-urban neighbourhood of Dakar was
34·2 %(22). Because of the difference when compared with
the above calculations, we employed both the values
(Table 3) to arrive at the indicated amount of mobilisable sto-
rage fat (8·7 and 12·4 kg), percentage of mobilisable wet AT
(20·4 and 29·0 %), and amount of DHA in mobilisable wet
AT (35 and 50 g). The DHA contents in whole-body fat were
60 and 75 g when differences in the DHA contents between
TAG and phospholipids were neglected (data not given in
Table 3). The milk-DHA outputs of the average Tanzanian-
Ukerewe woman were estimated to be 80 mg/d at day 3 and
to be 301 mg/d at 3 months postpartum.
The anthropometric data for the average 20–39-year-old US
woman in the 2003–2006 NHANES(27) were as follows: body
weight 73 kg; body length 163·2 cm; BMI 27·3 kg/m2, while
the body fat percentage in the 1999–2004 NHANES was
37·8 %(14). With these data, we estimated the amount of mobi-
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wet AT to be 33·5 %, and the amount of DHA in mobilisable
wet AT to be 19 g. The DHA content in whole-body fat was
28 g when differences in the DHA contents between TAG
and phospholipids were neglected (data not given in
Table 3). The milk-DHA output of the average US woman
was estimated to be 32 mg/d at day 3 and to be 60 mg/d at
3 months postpartum.
Discussion
We investigated DHA contents in the erythrocytes, milk and
AT of mother–infant pairs of four Tanzanian tribes having
lifetime stable dietary habits that reportedly do not change
during pregnancy and lactation. We were interested in the
interrelationships of the DHA contents in these compartments
and notably what amounts of milk-DHA and AT-DHA are
reached at an erythrocyte-DHA content of 8 wt%, which
leads to the lowest risk of CVD and mental illness in Western
populations(11,12). We also compared the estimated mobili-
sable AT-DHA pool size and the milk-DHA outputs of the
average Tanzanian-Ukerewe woman and compared the out-
comes with those of the average US woman.
Biomagnification
The present erythrocyte-DHA content data of mothers and
their children in various Tanzanian tribes confirm our previous
observation(13) that genuine biomagnification of DHA occurs
after birth (Table 2). At delivery, only infants with low DHA
status (Maasai and Pare) tended to have a higher erythro-
cyte-DHA content than their mothers, whereas infants with
high DHA status (Sengerema and Ukerewe) had a lower
erythrocyte-DHA content than their mothers. However, this
situation had changed after 3 months of exclusive breast-
feeding, when all the infants had a higher erythrocyte-DHA
content than their mothers, while all the mothers had a
lower erythrocyte-DHA content. Interestingly, the mothers
with low DHA status (Maasai) were unable to prevent a
decline of their infants’ erythrocyte-DHA content from delivery
to 3 months, while those with intermediate DHA status (Pare)
maintained their infants’ erythrocyte-DHA content and those
with high DHA status maintained (Ukerewe) or augmented
(Sengerema) their infants’ erythrocyte-DHA content. These
observations are consistent with the following: (1) intra-
uterine biomagnification as a sign of low (possibly
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Fig. 1. Relationships between maternal erythrocyte-DHA content at delivery and colostrum-DHA content (a) and between maternal erythrocyte-DHA content at
3 months postpartum (PP) and milk-DHA content at 3 months PP (b). Data obtained for the Sengerema (A; high fish intake; n 30 at delivery and n 47 at 3 months
PP) and Ukerewe (†; very high fish intake; n 20 at 3 months PP) groups are shown. (a) y ¼ 0·17e0·22x, R 2 0·510, P,0·001. (b) y ¼ 0·12e0·27x, R 2 0·324,
P,0·001.
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postnatal infant erythrocyte-DHA status if the mother has low
DHA status; (3) the importance of DHA notably after
delivery(13,32–34); (4) a deterioration of the maternal DHA
status during lactation that is independent of the prepreg-
nancy DHA status. Consistent with the notion that a major
proportion of at least linoleic acid (70 %) and AA (90 %) in
milk derives from AT stores(9), we found that mothers who
were unable to augment their infants’ DHA content during
lactation had the lowest AT-DHA contents (Maasai), while
those who were able to maintain their infants’ erythrocyte-
DHA content (Ukerewe) or even augment it (Sengerema)
had the highest AT-DHA contents (Table 2).
A drop in infant erythrocyte-DHA content after delivery may
obviously be prevented by maternal DHA supplementation,
since oral supplementation leads to a rapid dose-dependent
response of the milk-DHA(35). This strategy may, however,
be distinct from the lifetime high DHA consumption, as prac-
tised by, for example, the Tanzanian-Ukerewe mothers. The
difference becomes reflected in the steepness of the DHA
dose v. milk-DHA response curves in which the curve for life-
time intake is steeper than the one derived from a 12-week
DHA supplementation study(36). The fetomaternal unit has
an enormous DHA distribution volume and equilibration of
a DHA supplement among the maternal organs and possibly,
to a lesser extent, the infant organs, may take a considerable
time. The AT compartment exhibits the ‘last-in first-out’
phenomenon(37), while there is also selective mobilisation of
the individual fatty acids from AT, possibly because the
(more polar) PUFA in TAG have a tendency to accumulate
at the surface of the AT TAG droplet(38). This implies that nota-
bly the infant (via the milk) and the easily accessible organs of
the mother would benefit first and also that AT locations with
a low turnover (e.g. essential fat) and the maternal brain
would benefit last. It has been estimated that the half-life of
DHA in the adult human brain approximates 2·5 years(39),
which suggests that more than a decade of supplementation
is needed to reach a new equilibrium in the maternal brain(40).
Milk-DHA content of 1 wt% might be optimal for
(Western) infants
We found that a maternal erythrocyte-DHA content of 8 wt%
corresponds with a (mature) milk-DHA content of about
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AbdAT-DHA (wt%) at delivery
Fig. 2. Relationships between DHA contents in the subcutaneous adipose tissue (ScAT) (a) and abdominal adipose tissue (AbdAT) (b) and maternal erythrocyte-
DHA content at delivery. Data obtained for the Sengerema (A; high fish intake; n 37), Pare (V; intermediate fish intake; n 17) and Maasai (D; low/no fish intake;
n 2) groups are shown. (a) y ¼ 1·54 ln(x) þ 9·45, R 2 0·436, P,0·001. (b) y ¼ 1·38 ln(x) þ 8·89, R 2 0·432, P,0·001.
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AT-DHA contents of about 0·39 and 0·52 wt%, respectively
(Fig. 2(a) and (b)). A colostrum-DHA content of 1 wt% was
also found to correspond with subcutaneous and abdominal
AT-DHA contents in the same order of magnitude (0·35 and
0·40 wt%, respectively; Fig. 3(a) and (b)). These interrelation-
ships seem valid, since they derive from populations who
are at equilibrium because of their lifetime stable dietary
habits. They remain, however, no more than mean estimates,
since the relationships were subject to considerable inter-
individual scatter. It has been shown that an n-3 index
(i.e. erythrocyte-(EPA þ DHA) content) of 8 % in Western
populations is associated with the lowest cardiovascular
risk(11) and lowest psychiatric disease risk(12). The erythro-
cyte-DHA content constitutes the major part of this index.
One may consequently argue that 1 wt% DHA in human
milk is the optimum content for Western infants, which
coincides with a maternal AT-DHA contents of about 0·40 wt%
DHA. With this combination and continuing maternal dietary
habits, infants also achieve an erythrocyte-DHA content of
8 wt% after 3 months of lactation (Table 2), but probably
much sooner.
Recommendations have been made previously for adults,
pregnant and lactating women, and infants separately, without
consideration that these life stages and physiological con-
ditions are intimately connected. The current recommendation
for formula-fed infants is at least 0·2 wt% DHA to achieve
benefits on functional end points, but no more than 0·5 wt%
DHA because systematic evaluation above this level has not
been published(41). First of all, this recommendation is not
in line with the advisory of 200 mg DHA per d for lactating
women, since a maternal dietary intake of 200 mg already cor-
responds to 0.52 wt% in her milk; so in practice, those two
recommendations simply are at odds with each other.
Second, it ignores the observation that intakes of up to 1 g
DHA by lactating women have been studied without signifi-
cant adverse effects(36). Third, higher recommendations than
the presently encountered are in agreement with our deri-
vation from the water–land ecosystem(42–45). Finally, much
higher maternal milk contents have been observed in perfectly
healthy populations. For instance, milk-DHA levels compar-
ably high as those in Tanzanian-Ukerewe women have been
reported to be present in the colostrum of Japanese mothers
(1·1 wt%)(46), while Arctic Canadian (1·4 wt%)(47) and Kerewe
women in a previous study (1·8 wt%)(48) have been reported
to exhibit even higher mature milk-DHA levels.
That the incidence of atherosclerotic disease in traditionally
living Maasai with much lower erythrocyte-DHA status than
8wt% (Table 2) and a milk-DHA content of only 0·20wt%(48) is,
nevertheless, low is testimony of a much more complicated risk
profile than might emerge from the study of a single nutrient for























































Fig. 3. Relationships between DHA contents in the subcutaneous adipose tissue (ScAT) (a) and abdominal adipose tissue (AbdAT) (b) at delivery and colostrum-
DHA content. Data obtained for the Sengerema group are shown (A; high fish intake; n 37). * Data point for an average American woman (0·2 wt%(30)) and
her subcutaneous AT-DHA content (0·1 wt%(29)). † Data point for the milk-DHA and corresponding AT-DHA contents of French women at day 5 of lactation
(milk-DHA content: 0·53 wt%; AT-DHA content: 0·09 wt%), as reported by Martin et al.(71). (a) y ¼ 0·18 ln(x) þ 1·19, R 2 0·193, P¼0·015. (b) y ¼ 0·22 ln(x) þ 1·20,

























Fig. 4. Relationship between subcutaneous adipose tissue (ScAT) and
abdominal adipose tissue (AbdAT)-DHA contents. Data obtained for the
Sengerema ( ; high fish intake; n 37), Pare ( ; intermediate fish intake; n 17)
and Maasai ( ; low/no fish intake; n 2) groups are shown. , y ¼ x.
y ¼ 1·17x þ 0·01, R 2 0·690, P,0·001.


















Downloaded from https://www.cambridge.org/core. Rijksuniversiteit Groningen, on 08 Nov 2018 at 11:26:37, subject to the Cambridge Core terms of use, available at
traditionally living Maasai consume healthier diets in general and
therefore probably have a less disturbed intestinal flora(50), a high
level of physical activity, sufficient sleep and no Western lifestyle-
associated stress, while smoking and obesity (Table 2) are rare.
Their low DHA intake is accompanied by a low intake of linoleic
acid from refined vegetable oils(13). A high intake of linoleic acid
adversely affects theEPAandDHAstatus(51),while ameta-analysis
of randomised controlled trials has shown that the replacement of
SFA with linoleic acid leads to a borderline insignificant higher
cardiovascular risk(52). Consequently, milk-DHA content should
preferably be in balance with the content of other milk fatty
acids, notably EPA, AA and linoleic acid, and we, therefore,
suggest taking the milk fatty acids of the Ukerewe women as a
combination that reads as follows: 0·96wt% DHA; 0·55wt% AA;
0·22wt% EPA; 9·32wt% linoleic acid (Table S3, available online).
Interrelationships between DHA contents of erythrocytes,
milk, subcutaneous adipose tissue and abdominal
adipose tissue
Maternal erythrocyte-DHA (Fig. 2) and milk-DHA (Fig. 3)
contents exhibited non-linear relationships with subcutaneous
and abdominal AT-DHA contents, suggesting that some
degree of DHA saturation takes place in erythrocytes and
milk at high AT-DHA levels. When compared with each
other, it seems that maternal erythrocyte-DHA saturates at
lower DHA status than milk-DHA (Fig. 1), which may be in
line with a more important functional role of DHA in erythro-
cyte membranes, e.g. maintenance of fluidity, flexibility and
membrane-bound protein functions. Gibson et al.(53)
showed that with increasing maternal DHA intakes, the
milk-DHA content continues to increase, but that from
about 0·8 wt% DHA in milk, corresponding with an infant
erythrocyte-DHA content of approximately 9 wt% (with a
maximum of 12 wt%), no appreciable change occurs in the
infant erythrocyte-DHA content. Similar apparent saturation
of the adult erythrocyte-DHA was observed in the present
study, where, with increasing AT-DHA contents in the
Maasai, Pare and Sengerema women, maternal erythrocyte-
DHA content seemed to reach a plateau of about 9 wt%
(Fig. 2), while even higher individual maternal erythrocyte-
DHA (up to 11·10 wt%) and infant erythrocyte-DHA (up to
10·98 wt%) contents were reached in the Ukerewe women
(Table 2). An individual maximum erythrocyte-DHA content
of about 11–12 wt% is also in agreement with our previous
study, where the maximum content was 11·2 wt%(54). It is plaus-
ible that the erythrocyte-DHA content levels off with increasing
DHA status, while this may be the case for the AT-DHA content
to a much lesser extent. A consequence might be that the eryth-
rocyte-DHA content in the high range may become a less
reliable proxy for estimating whole-body, notably AT, DHA con-
tents. However, it should be noted that each of the encountered
relationships was subject to considerable scatter with few
subjects having very high AT-DHA contents, while a more
active turnover of AT and de novo fatty acid synthesis in preg-
nancy may preclude extrapolation to the non-pregnant
conditions.
On average, about 17 % higher DHA content in abdominal
(omental) AT, compared with that in subcutaneous AT, also
resulted from considerable scatter (Fig. 4), with a tendency
of higher omental AT-DHA contents notably at high DHA
status. Visceral AT, in contrast to subcutaneous AT, drains
directly through the portal circulation to the liver and is meta-
bolically more active with, for example, higher lipogenic and
lipolytic activities and higher capacity for the generation of
NEFA and glucose uptake(55,56). The remarkably small
Table 3. Estimated milk-DHA output and whole-body adipose tissue DHA content for an average Tanzanian-Ukerewe woman compared with an
average US woman
Dimension Tanzanian-Ukerewe Reference Average US Reference
Age (years) 26 Table 1 20–39
Body weight (kg) 54·6 Table 1 73 (27)
Body length (cm) 157 Table 1 163·2 (27)
BMI (kg/m2) 22·2 Table 1 27·3 (27)
Erythrocyte-DHA content (wt%) 8·0 Fig. 1 3·71 (28)
Body fat percentage (%) 27·5/34·2 (20–22) 37·8 (14)
Essential body fat percentage (%) 11·5 (15) 11·5 (15)
Storage fat percentage (mobilisable) (%) 16·0/22·7 26·3
Storage fat (mobilisable) (kg) 8·7/12·4 19·2
Percentage of fat in adult wet adipose tissue (%) 78·4 (23) 78·4 (23)
Mobilisable wet adipose tissue (kg) 11·1/15·8 24·5
Percentage of mobilisable wet adipose tissue (%) 20·4/29·0 33·5
Percentage of DHA in adipose tissue fat (g/100 g FA) 0·40 Fig. 3 0·10 (29)
DHA in mobilisable wet adipose tissue (g) 35/50 19
Colostrum volume at day 3 (ml/d) 393 (24) 393 (24)
Colostrum fat concentration at day 3 (g/l) 20·4 (25) 20·4 (25)
Colostrum-DHA content at day 3 (g/100 g FA) 1·0 Fig. 1 0·4 (31)
Colostrum-DHA output (mg/d) 80 32
Mature milk volume at 3 months (ml) 772 (24) 772 (24)
Mature milk fat content at 3 months (g/l) 39·0 (26) 39·0 (26)
Mature milk-DHA content at 3 months (g/100 g FA) 1·0 Fig. 1 0·2 (30)
Mature milk-DHA output (mg/d) 301 60
FA, fatty acid.
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differences between the DHA contents of omental and
subcutaneous AT might suggest that the women in the present
study with lifetime stable dietary habits are at a high degree of
DHA equilibrium, with little influence of dilution by de novo
synthesised fatty acids in the more metabolically active omen-
tal AT. However, no appreciable differences in DHA contents
between omental and subcutaneous AT have also been
observed previously in overweight and obese
Spanish patients(57,58), but in contrast to subcutaneous
AT-DHA content, an inverse relationship of omental AT DHA
with waist:hip ratio and visceral abdominal area has been
observed(57), suggesting that subjects with low central
adiposity have a higher omental AT-DHA content, but not a
higher subcutaneous AT-DHA content.
The mature milk-DHA content of the average US woman(30)
and her subcutaneous AT-DHA content(29) and also the milk-
DHA and AT-DHA contents of French women at day 5 of
lactation as reported by Martin et al.(59) fitted reasonably
well with the relationships between the milk-DHA and
AT-DHA contents observed in the present study (Fig. 3),
although each of these data points from the literature was at
the lower end of the curve (Table 2). Leaf et al.(29)
supplemented fifteen men and women, some of them patients
with dyslipidaemic disorders, with a minimum of 10 g fish oil
containing 1·8 g EPA and 1·0 g DHA/d for 22 months (12–27
months) to achieve a subcutaneous AT-DHA content of
0·7 wt%. This amount is in the high range of the data given
in Table 2 and may provide some insights into the amounts
of EPA þ DHA consumed by the average Tanzanian-Ukerewe
woman who has an estimated subcutaneous AT-DHA content
half that amount (0·37 wt%). In this context, there might not be
a difference between the LCP n-3 bioavailability from fish-oil
supplements and that from fish, since the intake of 485 mg
EPA þ DHA/d from fish or fish oil for 16 weeks was equally
effective in increasing the EPA þ DHA content in erythrocytes
and plasma phospholipids(60). However, the comparison
might in reality be much more complex, for example, due to
differences between the Tanzanian women and Western
women in distribution volumes, body fat percentages,
consumption of other fatty acids (e.g. linoleic acid) and the
intake of (low-glycaemic index) carbohydrates, which may
stimulate de novo fatty acid synthesis.
Estimated milk-DHA output and whole-body adipose
tissue-DHA content
We estimated that, when compared with the average US
woman, the average Tanzanian-Ukerewe woman has about
2·2 times higher erythrocyte-DHA content, 1·8–2·6 times
higher DHA amounts in mobilisable AT (in g), and about 2·5
and 5·0 times higher DHA outputs via colostrum and mature
milk, respectively (Table 3). These values correspond with
about 1·5–2·2 times higher amounts of mobilisable wet AT
(in kg) in the average US woman, which dilutes her
AT-DHA content four times, compared with the average
Tanzanian-Ukerewe woman. The comparisons of the amounts
of AT DHA and AT might be somewhat confounded by racial
differences, because, at a given BMI, the Black population has
lower fat mass(61). Nevertheless, the four times higher dilution
of DHA in the mobilisable AT of the average US woman might
be an important reason for her five times lower mature
milk-DHA output and contrasts with her ‘only’ 1·8–2·6 times
lower total DHA content in mobilisable AT. Selective
mobilisation of DHA from AT has been suggested pre-
viously(38,62,63), but in the case of American women, this is
apparently of insufficient magnitude to compensate for their
relatively lower AT-DHA content.
Because of the seemingly more important influence of
dilution, and not due to the total amount of DHA in mobilisa-
ble AT, this situation might be considered as a state of ‘DHA
starvation in the midst of plenty’, because sizeable stores
are present but poorly available for transfer into the milk.
Theoretically, the amount of mobilisable DHA in the AT of
the average Western woman could support lactation at a
level of 1 wt% milk-DHA for 63 d. Insufficient mobilisation,
for example, caused by insufficient postpartum loss of the
AT that is gained during pregnancy(64), retained during
lactation(65) or already present before conception, might
also play a role in Western women. We have recently
observed that pregnant Tanzanian women have 55% higher
25-hydroxyvitamin D (25(OH)D) than non-pregnant women
and mothers shortly after delivery(16). No such increases in
25(OH)D amounts have been reported for Western women,
who typically do not change their 25(OH)D intakes during
pregnancy or even experience a decrease(66). Therefore,
more intense mobilisation of vitamin D, and also of DHA,
from AT during pregnancy of Tanzanian women is conceiva-
ble. Also vitamin D becomes stored in AT, vitamin D in
serum and AT are correlated(67) and fasting causes vitamin D
mobilisation in rats(68). Circulating 25(OH)D is inversely
related to body fat percentage(69) and overweight and obese
persons have lower 25(OH)D amounts. The high degree of
AT turnover during pregnancy, where we deal with ‘facilitated
anabolism and accelerated starvation’(70), might not be contin-
ued during lactation in Western women because of insufficient
weight loss or the consistent postprandial condition, both of
which apply for many mothers in Western countries.
Limitations
It should be noted that, because of local constraints, the data
at delivery/3 d postpartum and at 3 months postpartum were
collected from different groups. We interpreted the differences
in DHA contents between these groups in terms of longitu-
dinal changes, as based on between-group statistical differ-
ences. This reasoning seems justified because of the stable
dietary habits of each of these groups. The basal data given
in Table 3 were derived from various publications, and the
outcomes of the estimates may, therefore, be subject to size-
able deviations. It may also not be correct to use whole-
body AT percentages of non-pregnant woman for estimates
in pregnant and lactating counterparts. We made a distinction
between ‘essential’ and ‘non-essential (mobilisable)’ AT in
women, which is not supported by hard scientific evidence.
Without this distinction, the DHA pool sizes become obviously
bigger (see the Results section), but this does not change the
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conclusion that the average Tanzanian-Ukerewe woman has a
higher DHA content and less diluted DHA in many, if not all,
body compartments including those that can potentially
become mobilised. The low AT-DHA levels also deserve to
be mentioned, since low levels are subject to high analytical
errors that may add up to sizeable uncertainty when they
become multiplied by the large amount of body fat. We also
made no distinction between the DHA present in the (mobili-
sable) TAG in the AT and that present in the phospholipids of
its membranes. Another limitation might be that the groups
were of different sizes, with the Maasai group being notably
smaller. This small sample size resulted from the difficulty in
investigating the Maasai in their bomas. Although the numbers
were small, we included all the Maasai we could, since we
thought their data to be unique.
Conclusions
We conclude that intra-uterine biomagnification is a sign of
low maternal DHA status, that genuine biomagnification
occurs during lactation, that exclusively breast-feeding
mothers with low DHA status are unable to augment their
infants’ DHA status, and that exclusively breast-feeding
mothers lose DHA independent of their DHA status. Maternal
DHA supplementation may rapidly correct the maternal and
infant DHA status in easily accessible compartments, but it is
improbable that all organs of the mother (e.g. AT with low
turnover and brain) will benefit at similar rates as those of
the infant. We also found that a maternal erythrocyte-DHA
content of 8 wt% corresponds with a (mature) milk-DHA
content of about 1·0 wt% and subcutaneous and abdominal
AT-DHA contents of about 0·39 and 0·52 wt%, respectively.
Consequently, a mature milk-DHA content of 1 wt% might
be a target for Western human milk and infant formula,
since an erythrocyte-DHA content of about 8 wt% leads to
the lowest risk of cardiovascular and psychiatric diseases in
adults living in Western countries. Concomitant milk AA,
EPA and linoleic acid contents were 0·55, 0·22 and 9·32 wt%,
respectively. Interrelationships between DHA contents in
erythrocytes, milk and AT suggest that with increasing DHA
status, the erythrocyte-DHA content plateaus at about 9 wt%,
with an upper maximum of about 12 wt%, and it plateaus
more readily than the milk-DHA and AT-DHA contents.
When compared with the average Tanzanian-Ukerewe
woman, the average US woman has four times higher dilution
of AT DHA (0·4 v. 0·1 wt%) and five times lower mature milk-
DHA output (301 v. 60 mg/d), which contrasts with her ‘only’
1·8–2·6 times lower total DHA content in the AT (19 v.
35–50 g). This dilution of DHA occurs in conjunction with
the insufficient weight loss and the consistent postprandial
state that is typical for many Western women might contribute
to a state of DHA starvation in the midst of plenty.
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